We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited cont ...
Pembrolizumab and concurrent CRT, followed by pembrolizumab consolidation, provided long-term tumor control in previously untreated, unresectable, stage III NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback